Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

EF Hutton

Data updated

New York, NY, United States

EF Hutton is a global full-service investment bank focused on middle-market and emerging growth companies, with public and private offerings across debt and equity capital markets. Its website lists product offerings including investment banking and advisory, private credit, asset-backed finance, credit tenant lease and ground lease finance, private equity, and project and infrastructure finance. Public materials describe the firm as headquartered in New York, New York.

In the psychedelic ecosystem, EF Hutton is relevant primarily as a capital markets and research intermediary rather than as a dedicated psychedelic specialist. Public materials show the firm has provided sell-side research on small and mid-cap companies and has covered or advised companies in the broader mental health and biotech space, which can overlap with public psychedelic issuers, but its public positioning remains industry-agnostic rather than explicitly psychedelic-focused.

Investor Context

Institutional Investors

Investment Context

This stakeholder is listed as an Institutional Investor within Institutional Investors. Its public geography context is global. Public stage signals include Growth / Late Stage, Public Markets, and Multi-Stage. Public focus areas include Drug Development.

Public Portfolio Examples

  • EF Hutton Acquisition Corporation ISPAC IPO - $115,000,000 - Sep 1, 2022

EF Hutton appears to be an investment banking platform oriented toward middle-market and emerging growth issuers, with capabilities spanning advisory, private credit, and public financing. Its public research and capital-markets activity suggest it may interact with companies in the psychiatric, biotech, and public micro-/small-cap universe, but there is no clear public indication of a dedicated psychedelic investing mandate.

Investor Type

Institutional Investor

Geographic Scope

Global

Psychedelic Focus

No Public Psychedelic Focus

Engagement

Active

Investment Stage Focus

Growth / Late StagePublic MarketsMulti-Stage

Investment Focus Areas

Drug Development

Investment Orientation

Engagement Status

Active

Investor Type

Institutional Investor

Investment Website

Recorded Investments

EF Hutton Acquisition Corporation I

Sep 1, 2022

SPAC IPO - $115,000,000

Public markets transaction tied to the EF Hutton platform rather than a psychedelic issuer.

EF Hutton home page transaction listing

Quick Facts

Founded
2020
HQ
New York, NY, United States
Website
Visit